Bullish vs. Bearish (1 opinions)
Social Sentiment 0.00
ADAP Forecast and Technical Stock Analysis
Hold candidate since 2020-01-23 Loss -2.73% PDF
Adaptimmune Therapeutics plc fell by -2.73% in the last day ( Friday, 24th Jan 2020 ) from $4.03 to $3.92 During the day the stock fluctuated 7.28% from a day low at $3.81 to a day high of $4.09. The price has risen in 6 of the last 10 days and is up by 186.13% over the past 2 weeks. Volume has increased in the last day by 1.12 million shares but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 1.94 million shares bought and sold for approximately $7.61 million.
- 30 day high of the ADAP stock price was $6.00 and low was $1.15.
- 90 day high was $6.00 and low was $0.71.
- 52 week high for Adaptimmune Therapeutics plc - $6.00 and low - $0.71.
Adaptimmune Therapeutics plc lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 131.59% during the next 3 months and, with 90% probability hold a price between $6.34 and $10.87 at the end of this period.
There are mixed signals in the stock today. A sales signal was issued from a pivot top point on Friday January 17, 2020, which indicates further falls until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely. Adaptimmune Therapeutics plc holds a sales signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately $4.22. On a fall, the stock will find some support from the long-term average at approximately $2.01. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sales signal.
Relative Strength Index (RSI)
RSImin/max Values: [ 20 - 75 ]
The stock holds a RSI14 at 83 and is currently being overbought on RSI. This does not have to be a sales signal as many stocks may go both long and hard while being overbought on the RSI. It is therefore important to evaluate the history of the share as it may tell you something about the RSI-sensitiveness.
* Stockinvest.us uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behaviour.
Support & Resistance
There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.28 between high and low, or 7.28%. For the last week, the stock has had a daily average volatility of 11.52%.
Our recommended stop-loss: $3.75 (-4.34%) (This stock has very high daily movements and this gives very high risk. The RSI14 is 83 and this increases the risk substantially. There is a sell signal from pivot top found 4 day(s) ago.)
11.52 %Average volatility
Very Low Low Medium High Very High
Adaptimmune Therapeutics plc holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as hold candidate (hold or accumulate) in this position whilst awaiting further development.
|ADAP $3.92 ($-0.11 -2.73%)|
ADAP is down $0.11 today, but where's it headed in 2020?
|Zacks Investment Research is releasing its prediction for ADAP based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the ADAP analysis is free »
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.